Metric Finance
LearnFAQ
LearnFAQ

Learn / ERAS

NASDAQ: ERAS

Erasca (ERAS) stock, explained like you're 5

Erasca trades on the Nasdaq under the ticker ERAS. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 5.6 billion dollars.

Ticker
ERAS
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Mid cap, about 5.6 billion dollars

Is Erasca a small, medium or large cap company?

No. Erasca is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 5.6 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Erasca makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ERAS stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • ERAS Stock Slumps Nearly 40% After Hours: Fine Print In 'Positive' Cancer Trial Reveals Treatment Related Death (Stocktwits)
  • (ERAS) Movement Within Algorithmic Entry Frameworks (Stock Traders Daily)
  • Erasca, Inc: The Discount RevMed? (NASDAQ:ERAS) (Seeking Alpha)
  • An 8,333 share Erasca (ERAS) sale is proposed by Erasca Foundation, with shares valued at $122K. (Stock Titan)
  • Erasca (ERAS) Stock Looks Overvalued On Price But Strong On Returns (Yahoo Finance)

Follow ERAS in your daily brief

Each trading day at 5 PM ET we post what happened to Erasca and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow ERAS

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Erasca stock

What does Erasca do?

Erasca trades on the Nasdaq under the ticker ERAS. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 5.6 billion dollars.

What is the ticker symbol for Erasca?

Erasca trades under the ticker ERAS on the Nasdaq.

What is Erasca's market cap?

Erasca is a mid cap stock with a market cap of about 5.6 billion dollars.

How does Erasca make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ERAS stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ERAS stock every day?

Add ERAS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow ERAS daily

A free brief on Erasca and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare ERAS: ERAS vs NVS, ERAS vs AZN, ERAS vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed